87 related articles for article (PubMed ID: 17125594)
1. Immunohistochemical evaluation of phosphorylated SMAD2/SMAD3 and the co-activator P300 in human glomerulonephritis: correlation with renal injury.
Kassimatis TI; Giannopoulou I; Koumoundourou D; Theodorakopoulou E; Varakis I; Nakopoulou L
J Cell Mol Med; 2006; 10(4):908-21. PubMed ID: 17125594
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor Sp1 expression is upregulated in human glomerulonephritis: correlation with pSmad2/3 and p300 expression and renal injury.
Kassimatis TI; Nomikos A; Giannopoulou I; Lymperopoulos A; Moutzouris DA; Varakis I; Nakopoulou L
Ren Fail; 2010 Jan; 32(2):243-53. PubMed ID: 20199187
[TBL] [Abstract][Full Text] [Related]
3. Effect of Smad pathway activation on podocyte cell cycle regulation: an immunohistochemical evaluation.
Koutroutsos K; Kassimatis TI; Nomikos A; Giannopoulou I; Theohari I; Nakopoulou L
Ren Fail; 2014 Sep; 36(8):1310-6. PubMed ID: 25026939
[TBL] [Abstract][Full Text] [Related]
4. Smad3 is acetylated by p300/CBP to regulate its transactivation activity.
Inoue Y; Itoh Y; Abe K; Okamoto T; Daitoku H; Fukamizu A; Onozaki K; Hayashi H
Oncogene; 2007 Jan; 26(4):500-8. PubMed ID: 16862174
[TBL] [Abstract][Full Text] [Related]
5. Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members.
Høj Thomsen L; Fog-Tonnesen M; Nielsen Fink L; Norlin J; de Vinuesa AG; Krarup Hansen T; de Heer E; Ten Dijke P; Rosendahl A
Nephron; 2017; 135(4):291-306. PubMed ID: 28064277
[TBL] [Abstract][Full Text] [Related]
6. Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response.
Tu AW; Luo K
J Biol Chem; 2007 Jul; 282(29):21187-96. PubMed ID: 17478422
[TBL] [Abstract][Full Text] [Related]
7. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease.
Goumenos DS; Tsamandas AC; Oldroyd S; Sotsiou F; Tsakas S; Petropoulou C; Bonikos D; El Nahas AM; Vlachojannis JG
Nephron; 2001 Mar; 87(3):240-8. PubMed ID: 11287759
[TBL] [Abstract][Full Text] [Related]
9. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
10. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
11. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K
Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
[TBL] [Abstract][Full Text] [Related]
12. Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney.
Banas MC; Parks WT; Hudkins KL; Banas B; Holdren M; Iyoda M; Wietecha TA; Kowalewska J; Liu G; Alpers CE
J Histochem Cytochem; 2007 Mar; 55(3):275-85. PubMed ID: 17142805
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells.
Ko H; So Y; Jeon H; Jeong MH; Choi HK; Ryu SH; Lee SW; Yoon HG; Choi KC
Cancer Lett; 2013 Jul; 335(1):205-13. PubMed ID: 23419524
[TBL] [Abstract][Full Text] [Related]
14. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
Arakawa T; Masaki T; Hirai T; Doi S; Kuratsune M; Arihiro K; Kohno N; Yorioka N
Nephrol Dial Transplant; 2008 Nov; 23(11):3418-26. PubMed ID: 18556750
[TBL] [Abstract][Full Text] [Related]
15. Expression of bcl-2 oncoprotein in various types of glomerulonephritis and renal allografts.
Nakopoulou L; Stefananki K; Papadakis J; Boletis J; Zeis PM; Kostakis A; Vosnides G
Nephrol Dial Transplant; 1996 Jun; 11(6):997-1002. PubMed ID: 8671959
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-κB and Smad2/3 Signaling.
Chen YM; Chiang WC; Yang Y; Lai CF; Wu KD; Lin SL
Mol Med; 2015 Apr; 21(1):276-84. PubMed ID: 25879629
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma.
Sitaram RT; Mallikarjuna P; Landström M; Ljungberg B
Oncotarget; 2016 Jun; 7(24):35917-35931. PubMed ID: 27166254
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
19. Regionally different immunoreactivity for Smurf2 and pSmad2/3 in TDP-43-positive inclusions of amyotrophic lateral sclerosis.
Nakamura M; Kaneko S; Wate R; Asayama S; Nakamura Y; Fujita K; Ito H; Kusaka H
Neuropathol Appl Neurobiol; 2013 Feb; 39(2):144-56. PubMed ID: 22435645
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.
Nakamura M; Ito H; Wate R; Nakano S; Hirano A; Kusaka H
Acta Neuropathol; 2008 Mar; 115(3):327-34. PubMed ID: 18210139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
